{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:33:12Z","timestamp":1771018392001,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.amjoto.2005.11.015","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T14:20:53Z","timestamp":1153491653000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy\/safety of amoxicillin\/clavulanate in adults with bacterial rhinosinusitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Jack B.","family":"Anon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elchonon","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Twynholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2005.11.015_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/clinids\/23.6.1209","article-title":"Acute community-acquired sinusitis","volume":"23","author":"Gwaltney","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.amjoto.2005.11.015_bib2","first-page":"29S","article-title":"Acute bacterial rhinosinusitis: clinical impact of resistance and susceptibility","volume":"117","author":"Poole","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.amjoto.2005.11.015_bib3","first-page":"40","article-title":"Sinusitis: a review for generalists","volume":"163","author":"Reuler","year":"1995","journal-title":"West J Med"},{"issue":"Suppl 1","key":"10.1016\/j.amjoto.2005.11.015_bib4","first-page":"23S","article-title":"Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae","volume":"117","author":"Anon","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.amjoto.2005.11.015_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otohns.2003.12.003","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"130","author":"Anon","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"Suppl C","key":"10.1016\/j.amjoto.2005.11.015_bib6","first-page":"15","article-title":"Microbiology and immunology of the nose and sinuses in acute rhinosinusitis","volume":"15","author":"Bernstein","year":"1998","journal-title":"Infect Med"},{"key":"10.1016\/j.amjoto.2005.11.015_bib7","series-title":"Sinusitis. Principles and practices of infectious diseases","author":"Gwaltney","year":"1995"},{"key":"10.1016\/j.amjoto.2005.11.015_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0091-6749(92)90169-3","article-title":"The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies","volume":"90","author":"Gwaltney","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjoto.2005.11.015_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjoto.2005.11.015_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00005537-200006000-00030","article-title":"Sinus tissue pharmacokinetics after oral administration of amoxicillin\/clavulanic acid","volume":"110","author":"Dinis","year":"2000","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"10.1016\/j.amjoto.2005.11.015_bib11","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkh050","article-title":"Augmentin\u00ae (amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent","volume":"53","author":"White","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjoto.2005.11.015_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjoto.2005.11.015_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00006454-199610000-00032","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in otitis media","volume":"15","author":"Craig","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.amjoto.2005.11.015_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/AAC.43.1.29","article-title":"Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory infections caused by strains of Streptococcus pneumoniae","volume":"43","author":"Woodnutt","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjoto.2005.11.015_bib15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0149-2918(01)80061-8","article-title":"The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin\/clavulanate","volume":"23","author":"Kaye","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjoto.2005.11.015_bib16","series-title":"Performance standards for antimicrobial susceptibility testing, 13th informational supplement","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.amjoto.2005.11.015_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/030006059802600202","article-title":"A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults","volume":"26","author":"Clement","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amjoto.2005.11.015_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0194-5998(99)70269-X","article-title":"Comparison of the efficacy of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults","volume":"120","author":"Adelglass","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2005.11.015_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9343(92)90232-Z","article-title":"Clinical comparison of cefuroxime axetil and amoxicillin\/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis","volume":"93","author":"Camacho","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjoto.2005.11.015_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-8579(02)00126-7","article-title":"The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000\/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000\/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults","volume":"20","author":"Petitpretz","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjoto.2005.11.015_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jac\/dkg458","article-title":"Oral pharmacokinetically enhanced co-amoxiclav 2000\/125 mg, twice daily, compared with co-amoxiclav 875\/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults","volume":"52","author":"Garau","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjoto.2005.11.015_bib22","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/AAC.48.9.3323-3331.2004","volume":"48","author":"File","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjoto.2005.11.015_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/AAC.46.2.371-377.2002","article-title":"Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and eastern European countries","volume":"46","author":"Nagai","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 9A","key":"10.1016\/j.amjoto.2005.11.015_bib24","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/S0002-9343(01)01025-7","article-title":"Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment","volume":"111","author":"Pfaller","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjoto.2005.11.015_bib25","unstructured":"Poole MD, Ferguson BJ, J.-M. Klossek, et al. Pharmacokinetically enhanced amoxicillin\/clavulanate, 2000\/125 mg, twice daily for 10 days, in the treatment of acute bacterial rhinosinusitis. Ear Nose Throat J [in press]."}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070905002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070905002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:53:31Z","timestamp":1759294411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070905002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0196070905002280"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2005.11.015","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy\/safety of amoxicillin\/clavulanate in adults with bacterial rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2005.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}